# Difference of Surgical Site Infection Between Using Sodium Picosulfate Solution(PicosolutionⓇ) and Oral Sulfate Tablet(ORA·FANGⓇ) in Colorectal Cancer Surgery

> **NCT04593446** · PHASE2 · UNKNOWN · sponsor: **National Cancer Center, Korea** · enrollment: 414 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Oral Sulfate Tablet(ORA·FANGⓇ)
- **DRUG:** Sodium Picosulfate Solution(PicosolutionⓇ)

## Key facts

- **NCT ID:** NCT04593446
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 414 (ESTIMATED)
- **Last updated:** 2020-10-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04593446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04593446, "Difference of Surgical Site Infection Between Using Sodium Picosulfate Solution(PicosolutionⓇ) and Oral Sulfate Tablet(ORA·FANGⓇ) in Colorectal Cancer Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04593446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*